Long-term administration of atrial natriuretic peptide in patients with acute heart failure.
A short-term treatment of atrial natriuretic peptide (ANP), a circulating hormone of cardiac origin, is reported to improve cardiac performance in patients with chronic heart failure. However, clinical usefulness of long-term administration of ANP in patients with congestive heart failure has not been reported. We studied 36 patients with severe acute heart failure who resisted various therapy. Hemodynamic parameters were measured before and 48 h after initiating ANP infusion (n = 18) or normal saline (n = 18). Mean pulmonary capillary wedge pressure (23-->13 mm Hg), mean right atrial pressure (10-->5 mm Hg), systemic vascular resistance (2,169-->1,307 dyn x s x cm(-5)) and pulmonary vascular resistance (318-->136 dyn x s x cm(-5)) decreased significantly, whereas cardiac index (1.9-->2.6 L/min/m2) and urine volume (1,692-->2,560 ml/day) increased during long-term ANP infusion (before-->48 h). Moreover, in eight patients with long-term ANP infusion, these hemodynamic effects were maintained at 7 days after initiating ANP infusion. Vasodilating, pulmonary vasorelaxant, and diuretic activities of ANP are maintained without tolerance, and thus long-term ANP infusion is clinically useful in patients with severe acute heart failure.
Kitashiro
S
S
The Second Department of Internal Medicine, Kansai Medical University, Moriguchi-City, Osaka, Japan.
Sugiura
T
T
Takayama
Y
Y
Tsuka
Y
Y
Izuoka
T
T
Tokunaga
S
S
Iwasaka
T
T
D000208:Acute Disease / Q000628:therapy; D000368:Aged; D009320:Atrial Natriuretic Factor / Q000627:therapeutic use*; D001774:Blood Chemical Analysis; D004231:Diuresis / Q000187:drug effects*; D004347:Drug Interactions; D004361:Drug Tolerance; D005260:Female; D006333:Heart Failure / Q000188:drug therapy*; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D008297:Male; D013997:Time Factors
D009320:Atrial Natriuretic Factor